| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2012-01-09 | Relovair® | chronic obstructive pulmonary disease (COPD) asthma |
3 | GSK (UK) Theravance (USA) | Allergic diseases - Inflammatory diseases - Respiratory diseases |
| 2011-12-30 | AT001/r84 | cancer | 1 | Affitech (Sweden) IBC Generium (Russia) | Cancer - Oncology |
| 2011-12-21 | GLPG0974 | inflammatory diseases | 1 | Galapagos (Belgium) | Inflammatory diseases |
| 2011-12-21 | JX-594/TG6006 (Pexa-Vec) | colorectal cancer | 2a | Transgene (France) Jennerex (USA) | Cancer Oncology |
| 2011-12-20 | Cx621 | Autoimmune diseases | 1 | Tigenix (Belgium) | Autoimmune diseases |
| 2011-12-20 | Teriflunomide | relapsing multiple sclerosis | 3 | Genzyme (USA), a Sanofi company (France) | Autoimmune diseases - Neurodegenerative diseases |
| 2011-12-20 | Rasilez®/Tekturna® (aliskiren) | hypertension in a specific population of patients with type 2 diabetes and renal impairment. | 3 | Novartis (Switzerland) | Cardiovascular diseases |
| 2011-12-20 | olaparib | serous ovarian cancer |
2 | AstraZeneca (UK) | Cancer Oncology |
| 2011-12-20 | TC-5214 | major depressive disorder (MDD) | 3 | AstraZeneca (UK) | CNS diseases - Mental diseases |
| 2011-12-19 | GLPG0778 | 1 | Galapagos (Belgium) GSK (UK) | Inflammatory diseases | |
| 2011-12-19 | ALKS 9070 | schizophrenia |
3 | Alkermes (Ireland) | Mental diseases - CNS diseases |
| 2011-12-15 | Gilenya® (fingolimod) | relapsing-remitting multiple sclerosis (RRMS) |
3 | Novartis (Switzerland) | Autoimmune diseases - Neurodegenerative diseases |
| 2011-12-15 | Benlysta® (belimumab) | systemic lupus erythematosus (SLE) | 3 | GSK (UK) Human Genome Sciences (USA) | Autoimmune diseases |
| 2011-12-15 | AX200 | acute ischemic stroke | 2 | Sygnis Pharma (Germany) | Cerebrovascular diseases |
| 2011-12-13 | INC424 (ruxolitinib) | myelofibrosis | 3 | Novartis (Switzerland) | Cancer - Oncology - Blood diseases |
| 2011-12-13 | INC424 (ruxolitinib) | myelofibrosis | 3 | Novartis (Switzerland) | Cancer - Oncology - Blood diseases |
| 2011-12-13 | olesoxime | amyotrophic lateral sclerosis | 3 | Trophos (France) | Neurodegenerative diseases - Neuromuscular diseases |
| 2011-12-13 | NI-1401-RG7624 | 1 | Genentech a member of the Roche Group (USA-Switzerland) - NovImmune (Switzerland) | ||
| 2011-12-13 | Exjade® (deferasirox) | non-transfusion-dependent thalassemia (NTDT)
|
3 | Novartis (Switzerland) | Hematological diseases - Genetic diseases |
| 2011-12-12 | ALX-0761 | autoimmune diseases |
preclinical | Ablynx (Belgium) Merck Serono (Germany) | Autoimmune diseases |
